Integral Ad Science (IAS 13.94%), a leader in digital ad verification, delivered its fourth-quarter earnings results on Feb. 28. The company reported revenue of $153 million, exceeding analysts' consensus estimate of $148 million and its own guidance range of $148 million to $150 million.
Fourth quarter revenue increased 14% to $153 million Fourth quarter net income of $15.3 million at a 10% margin; fourth quarter adjusted EBITDA increased 29% to $61.4 million at a 40% margin NEW YORK , Feb. 28, 2025 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a leading global media measurement and optimization platform, today announced financial results for the fourth quarter and full ye...
LOS ANGELES , Feb. 27, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Integral Ad Science Holding Corp. ("IAS" or the "Company") (NASDAQ: IAS) have opportunity to lead the securities fraud class action lawsuit.
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Integral Ad Science Holding Corp. (NASDAQ: IAS). Shareholders who purchased shares of IAS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Integral Ad Science Holding Corp. (NASDAQ: IAS).
NEW YORK , Feb. 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integral Ad Science Holding Corp. (NASDAQ: IAS) between March 2, 2023 and February 27, 2024, inclusive (the "Class Period"), of the important March 31, 2025 lead plaintiff deadline. So What: If you purchased IAS common stock during the Class Period you may be e...
BENSALEM, Pa. , Feb. 25, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.